Observational Study to Evaluate the Efficacy of Sustained QUTENZA® Use in Painful Diabetic Peripheral Neuropathy
Public ClinicalTrials.gov record NCT06495424. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Post-Market Observational Multi-Center Study to Evaluate the Effectiveness of Repeated QUTENZA Use in Adults With Painful Diabetic Peripheral Neuropathy of the Feet
Study identification
- NCT ID
- NCT06495424
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Averitas Pharma, Inc.
- Industry
- Enrollment
- 144 participants
Conditions and interventions
Interventions
- Capsaicin 8% Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 13, 2025
- Primary completion
- Feb 28, 2027
- Completion
- Feb 28, 2027
- Last update posted
- Apr 20, 2026
2025 – 2027
United States locations
- U.S. sites
- 10
- U.S. states
- 6
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Center for Interventional Pain and Spine | Wilmington | Delaware | 19808 | — |
| Horizon Clinical Research | Gainesville | Georgia | 30501 | — |
| Horizon Clinical Research | Jasper | Georgia | 30143 | — |
| Horizon Clinical Research | Newnan | Georgia | 30265 | — |
| Iqra Research | Edgewood | Kentucky | 41017 | — |
| Curalta Clinical Trials | Oradell | New Jersey | 07649 | — |
| Iqra Research | Cincinnati | Ohio | 45248 | — |
| Center for Interventional Pain and Spine | Bryn Mawr | Pennsylvania | 19010 | — |
| Center for Interventional Pain and Spine | Fort Washington | Pennsylvania | 19034 | — |
| Center for Interventional Pain and Spine | Lancaster | Pennsylvania | 17601 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06495424, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 20, 2026 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06495424 live on ClinicalTrials.gov.